Benjamin Philpot
Professor of neuroscience
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
Angelman syndrome: Bellwether for genetic therapy in autism
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.
Insights for autism from Angelman syndrome
Explore more from The Transmitter
Noninvasive method lifts curtain on cerebrospinal-fluid dance in human brain
Cerebrospinal fluid shows brain-region-specific dynamics, a new high-resolution MRI approach reveals.
Noninvasive method lifts curtain on cerebrospinal-fluid dance in human brain
Cerebrospinal fluid shows brain-region-specific dynamics, a new high-resolution MRI approach reveals.
Aging as adaptation: Learning the brain’s recipe for resilience
Some age-related changes in the brain and in behavior are not solely the result of cognitive decline but rather part of a larger adaptive process.
Aging as adaptation: Learning the brain’s recipe for resilience
Some age-related changes in the brain and in behavior are not solely the result of cognitive decline but rather part of a larger adaptive process.
Going against the gut: Q&A with Kevin Mitchell on the autism-microbiome theory
A new review of 15 years of studies on the connection between the microbiome and autism reveals widespread statistical and conceptual errors.
Going against the gut: Q&A with Kevin Mitchell on the autism-microbiome theory
A new review of 15 years of studies on the connection between the microbiome and autism reveals widespread statistical and conceptual errors.